- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07454447
UBM Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma
Ultrasound Biomicroscopy Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma
Primary open-angle glaucoma is a chronic optic neuropathy that often requires surgical intervention when medical treatment fails. Deep sclerectomy is a non-penetrating glaucoma surgery that aims to reduce intraocular pressure while minimizing complications. When combined with trabeculotomy, additional aqueous outflow may be achieved.
Ultrasound biomicroscopy (UBM) allows detailed imaging of the anterior segment and provides valuable information about postoperative anatomical changes that cannot be assessed clinically. This observational study aims to evaluate UBM findings after combined deep sclerectomy with trabeculotomy in patients with primary open-angle glaucoma and to correlate these findings with clinical outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective observational study conducted at Minia University Hospital on patients diagnosed with primary open-angle glaucoma who underwent combined deep sclerectomy with trabeculotomy. Patients are evaluated postoperatively using ultrasound biomicroscopy to assess anterior segment structures, including the intrascleral lake, filtering bleb characteristics, and trabeculo-Descemet membrane.
Clinical parameters such as intraocular pressure, number of antiglaucoma medications, and postoperative outcomes are recorded and correlated with UBM findings. The study aims to identify anatomical predictors of surgical success and to enhance understanding of postoperative changes following combined non-penetrating glaucoma surgery.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Minya Governorate
-
Minya, Minya Governorate, Egypt
- Recruiting
- Minia University Hospital
-
Contact:
- Ahmed Magdy Farouk, MD
- Phone Number: +201551416518
- Email: ahmed.magdy1077@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of primary open-angle glaucoma (POAG), including juvenile open-angle glaucoma (JOAG).
- Patients who underwent combined deep sclerectomy with trabeculotomy.
- Clear media allowing adequate ultrasound biomicroscopy imaging.
- Written informed consent obtained from the patient .
Exclusion Criteria:
- Secondary glaucomas (e.g., neovascular, uveitic, traumatic, or angle-closure glaucoma).
- Previous glaucoma filtering surgery in the studied eye.
- Coexisting ocular pathology affecting UBM assessment (e.g., severe corneal opacity, scleral pathology).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
POAG post-combined deep sclerectomy with trabeculotomy
Patients with primary open-angle glaucoma who underwent combined deep sclerectomy with trabeculotomy.
Postoperative assessment is performed using ultrasound biomicroscopy to evaluate intrascleral lake characteristics, filtering bleb morphology, and related anatomical parameters.
|
Ultrasound biomicroscopy is performed as a non-invasive diagnostic imaging procedure to evaluate postoperative anterior segment anatomy, including intrascleral lake characteristics and filtering bleb morphology, in patients with primary open-angle glaucoma following combined deep sclerectomy with trabeculotomy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intrascleral lake area on ultrasound biomicroscopy (UBM)
Time Frame: 3 and 6 months postoperatively
|
Quantitative measurement of intrascleral lake area (mm²) using ultrasound biomicroscopy after combined deep sclerectomy with trabeculotomy.
|
3 and 6 months postoperatively
|
|
Intrascleral lake height on ultrasound biomicroscopy (UBM)
Time Frame: 3 and 6 months postoperatively
|
Quantitative measurement of intrascleral lake height (mm) using ultrasound biomicroscopy after combined deep sclerectomy with trabeculotomy.
|
3 and 6 months postoperatively
|
|
Filtering bleb height on ultrasound biomicroscopy (UBM)
Time Frame: 3 and 6 months postoperatively
|
Quantitative measurement of filtering bleb height (mm) using ultrasound biomicroscopy after combined deep sclerectomy with trabeculotomy.
|
3 and 6 months postoperatively
|
|
Filtering bleb internal reflectivity on ultrasound biomicroscopy (UBM)
Time Frame: 3 and 6 months postoperatively
|
Semi-quantitative assessment of filtering bleb internal reflectivity on ultrasound biomicroscopy after combined deep sclerectomy with trabeculotomy.
|
3 and 6 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in intraocular pressure
Time Frame: 3 and 6 months postoperatively
|
Change in intraocular pressure (mmHg) from baseline to 3 and 6 months after combined deep sclerectomy with trabeculotomy.
|
3 and 6 months postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MUFMIRB-1766-11-2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Open Angle Glaucoma (POAG)
-
Huons Co., Ltd.RecruitingOcular Hypertension | Primary Open Angle Glaucoma (POAG)South Korea
-
Henry Ford Health SystemNot yet recruitingPrimary Open Angle Glaucoma (POAG) | Secondary Open Angle Glaucoma | Open Angle Glaucoma (OAG)United States
-
Select Eye CareRecruitingPrimary Open Angle Glaucoma (POAG)United States
-
Institut Catala de RetinaHospital de la EsperanzaRecruitingGlaucoma | Primary Open Angle Glaucoma (POAG) | NeuroprotectionSpain
-
Implandata Ophthalmic Products GmbHCompletedPrimary Open Angle Glaucoma (POAG)Germany
-
Iantrek, Inc.RecruitingPrimary Open Angle Glaucoma (POAG)United States
-
University Hospital, GrenobleNot yet recruitingPrimary Open-angle Glaucoma (POAG)
-
Alcon ResearchTranscend Medical, Inc.CompletedPrimary Open Angle Glaucoma (POAG)United States
-
Glostrup University Hospital, CopenhagenRecruitingGlaucoma | Open-Angle Glaucoma | Primary Open Angle Glaucoma (POAG)Denmark
-
Military Institute od Medicine National Research...RecruitingCataract | Primary Open-Angle Glaucoma (POAG)Poland
Clinical Trials on Ultrasound Biomicroscopy
-
Centre Hospitalier Universitaire de NiceRecruitingCutaneous MelanomaFrance
-
Randa Farouk KashifAin Shams UniversityCompletedSpasm of Accommodation
-
DAVID HAUSERUnknown
-
Medical University of ViennaCompletedCorneal Infiltrates | Corneal AbrasionsAustria
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Marwa AhmedRecruitingCorneal Endothelial Changes After PhacoemulsificationEgypt
-
Cairo UniversityCompletedPrimary Antiphospholipid SyndromeEgypt
-
Ahram Canadian UniversityCompletedCarpal Tunnel Syndrome | Median Neuropathy, Carpal TunnelEgypt
-
Eskisehir Osmangazi UniversityCompletedCarpal Tunnel Syndrome
-
Medicontur Medical Engineering LtdCompleted